Published in Drug Week, November 23rd, 2007
"PNIPAAm and Dex-MA precursors were chosen as thermo-sensitive and pH-sensitive components, respectively. Dex-MA was also used as a cross-linker. An anti-tumor drug, doxorubicin, was used to examine the effects of network structures of PNIPAAm/Dex-MA hydrogels on...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.